“[Limitations and potential of combined epigenetic and transcriptional analysis on a large scale to identify therapeutic targets in cardiovascular diseases]”, G Ital Med Lav Ergon, vol. 41, no. 4, pp. 328–332, Sep. 2019, doi: 10.4081/gimle.516.